Raymond James Financial Inc Lexaria Bioscience Corp. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Raymond James Financial Inc holds 60,640 shares of LEXX stock, worth $114,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,640Holding current value
$114,609% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.05MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA476KShares$899,2100.08% of portfolio
-
Geode Capital Management, LLC Boston, MA150KShares$284,2380.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA109KShares$206,0510.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$84,8610.0% of portfolio
-
State Street Corp Boston, MA39.3KShares$74,2780.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $11.2M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...